- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe active rheumatoid arthritis Severe psoriatic arthritis Ankylosing spondylitis Severe chronic plaque psoriasis Juvenile idiopathic arthritis
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Etanercept – July 2025
Etanercept; Injections 50 mg in 1 mL single use pre-filled syringes, 4; Nepexto®
Last updated
9 July 2025